Synthesis 2017; 49(05): 1024-1036
DOI: 10.1055/s-0036-1588894
paper
© Georg Thieme Verlag Stuttgart · New York

Palladium-Catalyzed Direct α-Arylation of p-Methoxybenzyl-Protected S,S-Dimethylsulfoximine

Juan A. Sirvent
a   Bayer Pharma AG, Drug Discovery, Müllerstr. 178, 13353 Berlin, Germany   Email: ulrich.luecking@bayer.com
,
Donald Bierer
b   Bayer Pharma AG, Drug Discovery, Aprather Weg 18a, 42113 Wuppertal, Germany
,
Robert Webster
b   Bayer Pharma AG, Drug Discovery, Aprather Weg 18a, 42113 Wuppertal, Germany
,
Ulrich Lücking*
a   Bayer Pharma AG, Drug Discovery, Müllerstr. 178, 13353 Berlin, Germany   Email: ulrich.luecking@bayer.com
› Author Affiliations
Further Information

Publication History

Received: 28 July 2016

Accepted after revision: 12 September 2016

Publication Date:
12 October 2016 (online)


Abstract

Sulfoximines have recently gained considerable recognition as an important structural motif in the life sciences. This is especially true for (hetero)aryl-substituted S,S-dimethylsulfoximine derivatives, such as the marketed insecticide sulfoxaflor, as well as the clinical candidates­ PTEFb inhibitor BAY 1143572 and ATR inhibitor AZD 6738 for the treatment of cancer. Herein, the first palladium-catalyzed direct α-arylation of p-methoxybenzyl-protected S,S-dimethylsulfoximine using readily available (hetero)aryl bromides is reported. This new method provides a safe, short, and efficient approach to (hetero)aryl-substituted­ S,S-dimethylsulfoximine derivatives, an important class of bioactive compounds, demonstrated by application of this methodology to an improved synthesis of PTEFb inhibitor BAY 1143572.

Supporting Information

Primary Data

 
  • References

  • 1 Bentley HR, McDermott EE, Pace J, Whitehead JK, Moran T. Nature 1949; 163: 675
  • 5 Lücking U. Angew. Chem. Int. Ed. 2013; 52: 9399
  • 9 Bizet V, Buglioni L, Bolm C. Angew. Chem. Int. Ed. 2014; 53: 5639
    • 10a Zhu Y, Loso MR, Watson GB, Sparks TC, Rogers RB, Huang JX, Gerwick BC, Babcock JM, Kelley D, Hedge VB, Nugent BM, Renga JM, Denholm I, Gorman K, DeBoer GJ, Hasler J, Meade T, Thomas JD. J. Agric. Food Chem. 2011; 59: 2950
    • 10b Lücking U, Jautelat R, Krüger M, Brumby T, Lienau P, Schäfer M, Briem H, Schulze J, Hillisch A, Reichel A, Wengner AM, Siemeister G. ChemMedChem 2013; 8: 1067
    • 10c Goldberg FW, Kettle JG, Xiong J, Lin D. Tetrahedron 2014; 70: 6613
    • 10d Goldberg FW, Kettle JG, Kogej T, Perry MW. D, Tomkinson NP. Drug Discovery Today 2015; 20: 11
    • 10e Nishimura N, Norman MH, Liu L, Yang KC, Ashton KS, Bartberger MD, Chmait S, Chen J, Cupples R, Fotsch C, Helmering J, Jordan SR, Kunz RK, Pennington LD, Poon SF, Siegmund A, Sivits G, Lloyd DJ, Hale C, St Jean DJ. Jr. J. Med. Chem. 2014; 57: 3094
    • 10f Boral S, Wang S, Malon T, Wurster J, Shen J, Robinson M (Allergan, Inc.) US Patent 20150166521, 2015 ; Chem. Abstr. 2015, 163, 118575.
    • 10g Blum A (Boehringer Ingelheim) Patent WO 2015169677, 2015 ; Chem. Abstr. 2015, 163, 702466.
    • 10h Johnson T, Vairagoundar R, Ewin RA (Zoetis LLC) Patent WO 2014172443, 2014 ; Chem. Abstr. 2014, 161, 647008.
    • 10i Nugent BM, Buysse AM, Loso MR, Babcock JM, Johnson TC, Oliver MP, Martin TP, Ober MS, Breaux N, Robinson A, Adelfinskaya Y. Pest Manage. Sci. 2015; 71: 928
    • 10j von Nussbaum F, Li VM.-J, Allerheiligen S, Anlauf S, Bärfacker L, Bechem M, Delbeck M, Fitzgerald MF, Gerisch M, Gielen-Haertwig H, Haning H, Karthaus D, Lang D, Lustig K, Meibom D, Mittendorf J, Rosentreter U, Schäfer M, Schäfer S, Schamberger J, Telan LA, Tersteegen A. ChemMedChem 2015; 10: 1163
    • 10k See also ref. 5, and references cited therein.
  • 12 Luecking U, Scholz A, Lienau P, Siemeister G, Kosemund D, Bohlmann R, Eis K, Gnoth M, Terebesi I, Meyer K, Prelle K, Valencia R, Ince S, von Nussbaum F, Mumberg D, Ziegelbauer K, Klebl B, Choidas A, Nussbaumer P, Baumann M, Schultz-Fademrecht C, Ruehter G, Eickhoff J, Brands M. Cancer Res. 2015; 75 (15 Suppl): Abstract No. 2828
  • 13 Foote KM, Lau A, Nissink JW. M. Future Med. Chem. 2015; 7: 873

    • See, for example:
    • 14a Lücking U, Krueger M, Jautelat R, Siemeister G (Schering AG) Patent WO 2005037800, 2005 ; Chem. Abstr. 2005, 142, 430288.
    • 14b Lücking U, Siemeister G, Jautelat R (Schering AG) Patent WO 2006099974, 2006 ; Chem. Abstr. 2006, 145, 377362.
    • 14c Lücking U (Schering AG) Patent EP 1710246, 2006 ; Chem. Abstr. 2006, 145, 438651.
    • 14d Lücking U, Kettschau G, Briem H, Schwede W, Schäfer M, Thierauch K.-H, Husemann M (Schering AG) Patent WO 2006108695, 2006 ; Chem. Abstr. 2006, 145, 419188.
    • 14e Luecking U, Nguyen D, von Bonin A, von Ahsen O, Krueger M, Briem H, Kettschau G, Prien O, Mengel A, Krolikiewicz K, Boemer U, Bothe U, Hartung I (Schering AG) Patent WO 2007071455, 2007 ; Chem. Abstr. 2007, 147, 95692.
    • 14f Lücking U, Siemeister G, Bader B (Schering AG) Patent WO 2007079982, 2007 ; Chem. Abstr. 2007, 147, 166339.
    • 14g Luecking U, Siemeister G, Jautelat R (Bayer Schering Pharma AG) Patent WO 2008025556, 2008 ; Chem. Abstr. 2008, 148, 331698.
    • 14h Prien O, Eis K, Lücking U, Guenther J, Zopf D (Bayer Schering Pharma AG) Patent DE 102007024470, 2008 ; Chem. Abstr. 2008, 150, 5753.
    • 14i Hartung I, Bothe U, Kettschau G, Luecking U, Mengel A, Krueger M, Thierauch K.-H, Lienau P, Boemer U (Bayer Schering Pharma AG) Patent WO 2008155140, 2008 ; Chem. Abstr. 2009, 150, 214413.
    • 14j Nguyen D, Von Bonin A, Haerter M, Schirok H, Mengel A, Von Ahsen O (Bayer Schering Pharma AG) Patent WO 2009089851, 2009 ; Chem. Abstr. 2009, 151, 173484.
    • 14k Härter M, Beck H, Ellinghaus P, Berhoerster K, Greschat S, Thierauch K.-H, Süssmeier F (Bayer Schering Pharma AG) Patent WO 2010054763, 2010 ; Chem. Abstr. 2010, 152, 568149.
    • 14l von Nussbaum F, Karthaus D, Anlauf S, Delbeck M, Li VM.-J, Meibom D, Lustig K, Schneider D (Bayer Schering Pharma AG) Patent WO 2010115548, 2010 ; Chem. Abstr. 2010, 153, 505832.
    • 14m Schwede W, Klar U, Möller C, Rotgeri A, Bone W (Bayer Schering Pharma AG) Patent WO 2011009531, 2011 ; Chem. Abstr. 2011, 154, 158660.
    • 14n Lücking U, Cleve A, Haendler B, Faus H, Köhr S, Irlbacher H (Bayer Schering Pharma AG) Patent WO 2011029537, 2011 ; Chem. Abstr. 2011, 154, 361030.
  • 15 Lücking U, Bohlmann R, Scholz A, Siemeister G, Gnoth MJ, Boemer U, Kosemund D, Lienau P, Ruether G, Schulz-Fademrecht C (Bayer Intellectual Property GmbH) Patent WO 2012160034, 2012 ; Chem. Abstr. 2012, 158, 37597.
  • 17 Zhou G, Ting PC, Aslanian RG. Tetrahedron Lett. 2010; 51: 939
  • 18 Zheng B, Jia T, Walsh PJ. Org. Lett. 2013; 15: 1690
  • 19 Nambo M, Crudden CM. Angew. Chem. Int. Ed. 2014; 53: 601
  • 23 For the cleavage of a PMB group via an intramolecular redox C–H activation process, see: Gao X, Gaddam V, Altenhofer E, Tata RR, Cai Z, Yongpruksa N, Garimallaprabhakaran AK, Harmata M. Angew. Chem. Int. Ed. 2012; 51: 7016
    • 24a Since only formed in low amounts, potential diarylation products were not isolated and fully characterized; the corresponding mass ion was detected in various intensities upon monitoring the coupling reactions by UPLC/MS.
    • 24b For the di­arylation of methyl sulfones, see ref. 17.
  • 25 Bruno N. Cross-Coupling Reaction Manual: Desk Reference. http://www.sigmaaldrich.com/content/dam/sigma-aldrich/docs/Aldrich/Method/1/83784-Cross-Coupling-Selection­-Brochure.pdf (accessed 9.9.2016)
  • 26 See, for example: Morita DK, Stille JK, Norton JR. J. Am. Chem. Soc. 1995; 117: 8576
  • 27 The racemate can be separated into the single enantiomers via chiral HPLC separation; see ref. 15.
  • 28 Yadav MR, Rit RK, Sahoo AK. Chem. Eur. J. 2012; 18: 5541
  • 29 García Mancheño O, Bistri O, Bolm C. Org. Lett. 2007; 9: 3809